The mucosal protein corona in local nanoparticle drug delivery
- 17 March 2025
- journal article
- Published by Elsevier in Cell Biomaterials
- Vol. 1 (2)
Abstract
No abstract availableKeywords
Funding Information
- University of Maryland University College Graduate School
- National Science Foundation Division of Chemical Bioengineering Environmental and Transport Systems (2047794)
- University of Maryland A James Clark School of Engineering
- University of Maryland
- University of Maryland, Baltimore
- National Heart Lung and Blood Institute (R01 HL160540)
- National Science Foundation
- National Institutes of Health
- Institute for Clinical and Translational Research, University of Maryland, Baltimore
This publication has 43 references indexed in Scilit:
- Disease-specific protein corona formed in pathological intestine enhances the oral absorption of nanoparticlesActa Pharmaceutica Sinica B, 2023
- Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel diseaseBiomaterials, 2018
- Protein Corona Liposomes Achieve Efficient Oral Insulin Delivery by Overcoming Mucus and Epithelial BarriersAdvanced Healthcare Materials, 2018
- The biology of mucus: Composition, synthesis and organizationAdvanced Drug Delivery Reviews, 2018
- Zwitterionic Modification of Ultrasmall Iron Oxide Nanoparticles for Reduced Protein Corona FormationChempluschem, 2017
- Mucus‐Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal SurfacesAdvanced Healthcare Materials, 2016
- Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell typeEnvironmental Toxicology and Chemistry, 2013
- The complement systemCell and tissue research, 2010
- Barrier properties of mucusAdvanced Drug Delivery Reviews, 2009
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009